RTI Surgical, Inc. (NASDAQ:RTIX) Scheduled to Post Quarterly Earnings on Tuesday
RTI Surgical, Inc. (NASDAQ:RTIX) is set to post its quarterly earnings results before the market opens on Tuesday, July 25th. Analysts expect RTI Surgical to post earnings of $0.02 per share for the quarter. RTI Surgical has set its FY17 guidance at $0.05-0.10 EPS.
RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings results on Thursday, April 27th. The medical equipment provider reported ($0.05) EPS for the quarter. The company had revenue of $69.90 million during the quarter, compared to analysts’ expectations of $67.68 million. RTI Surgical had a negative net margin of 6.85% and a positive return on equity of 1.34%. The business’s revenue for the quarter was up 3.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.03 earnings per share. On average, analysts expect RTI Surgical to post $0.07 EPS for the current fiscal year and $0.13 EPS for the next fiscal year.
RTI Surgical, Inc. (NASDAQ:RTIX) opened at 5.65 on Tuesday. RTI Surgical, Inc. has a 52 week low of $2.50 and a 52 week high of $6.00. The stock’s market capitalization is $328.41 million. The firm has a 50-day moving average of $5.18 and a 200 day moving average of $4.02.
Several research firms have issued reports on RTIX. ValuEngine upgraded RTI Surgical from a “sell” rating to a “hold” rating in a report on Friday, June 2nd. Zacks Investment Research upgraded RTI Surgical from a “hold” rating to a “buy” rating and set a $6.25 price target for the company in a report on Wednesday, June 28th. Finally, TheStreet upgraded RTI Surgical from a “d+” rating to a “c-” rating in a report on Friday, May 5th.
In other news, EVP Kevin D. Brandt purchased 33,130 shares of the stock in a transaction dated Wednesday, May 3rd. The stock was acquired at an average cost of $4.52 per share, for a total transaction of $149,747.60. Following the acquisition, the executive vice president now owns 126,215 shares of the company’s stock, valued at $570,491.80. The acquisition was disclosed in a filing with the SEC, which is available at this link. Also, CEO Camille Farhat purchased 61,693 shares of the stock in a transaction dated Thursday, May 18th. The stock was purchased at an average price of $4.65 per share, with a total value of $286,872.45. The disclosure for this purchase can be found here. Insiders bought a total of 112,023 shares of company stock valued at $514,421 over the last quarter. Company insiders own 4.90% of the company’s stock.
TRADEMARK VIOLATION WARNING: This piece of content was originally posted by American Banking News and is owned by of American Banking News. If you are reading this piece of content on another website, it was copied illegally and republished in violation of international copyright and trademark legislation. The original version of this piece of content can be accessed at https://www.americanbankingnews.com/2017/07/18/rti-surgical-inc-nasdaqrtix-scheduled-to-post-quarterly-earnings-on-tuesday.html.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.